Lionco Pharmaceutical Group (603669) Stock Price, News, Quotes-Moomoo

CN Stock MarketDetailed Quotes

603669 Lionco Pharmaceutical Group

Watchlist

8.00
+0.73+10.04%

Not Open Dec 4 15:00 CST

5.77BMarket Cap-56737P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Revenues Not Telling The Story For Lionco Pharmaceutical Group Co.,Ltd. (SHSE:603669) After Shares Rise 29%
Simply Wall StDec 3 19:10 ET
Is Lionco Pharmaceutical GroupLtd (SHSE:603669) Using Debt Sensibly?
Simply Wall StDec 2 19:08 ET
Company Report for the Third Quarter of 2024 (after correction)
SZSINov 29 11:00 ET · Announcements
Announcement on additional information to the 2024 Third Quarter Report
SZSINov 29 11:00 ET · Announcements
lionco pharmaceutical group (603669.SH) subsidiary cephalosporin sodium for injection passed the generic drug consistency evaluation.
Lionco Pharmaceutical Group (603669.SH) announced that its wholly-owned subsidiary Hainan Lionco Pharmaceutical Co., Ltd. (referred to as "...
Zhitong FinanceNov 5 02:54 ET
Lingkang Pharmaceutical: Third Quarter Report 2024
SZSIOct 30 12:00 ET · Announcements

Comments

Moomoo AI

Feb 2 17:45

Lionco Pharmaceutical GroupLtd's high P/S ratio is alarming due to its falling revenue. Unless there's a significant improvement in medium-term conditions, the current share price may not be considered fair value. The company's declining revenue and high P/S ratio could negatively impact the future share price.